FdaApplication

NDA 207500

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTELLAS PHARMA US INC
application_typeNDA
approval_date2015-03-06

Products (2)

ProductActive ingredientStrengthDosage form
CRESEMBAISAVUCONAZONIUM SULFATE186MGCAPSULE;ORAL
CRESEMBAISAVUCONAZONIUM SULFATE74.5MGCAPSULE;ORAL

2 products